Loncom Pharma's Smoking Cessation APIs are key components in developing treatments for nicotine addiction. These ingredients aid in reducing withdrawal symptoms and the urge to smoke, supporting individuals in their journey to quit smoking.
Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong Province, with a registered capital of 60 million yuan.
